Processa Pharmaceuticals Stock Price on April 5, 2024
| PCSA Stock | USD 1.16 0.18 18.37% |
Below is the normalized historical share price chart for Processa Pharmaceuticals extending back to November 21, 2013. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Processa Pharmaceuticals stands at 1.16, as last reported on the 30th of November, with the highest price reaching 1.17 and the lowest price hitting 1.00 during the day.
If you're considering investing in Processa Stock, it is important to understand the factors that can impact its price. Processa Pharmaceuticals maintains Sharpe Ratio (i.e., Efficiency) of -0.0429, which implies the firm had a -0.0429% return per unit of risk over the last 3 months. Processa Pharmaceuticals exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Processa Pharmaceuticals' Coefficient Of Variation of (2,169), risk adjusted performance of (0.03), and Variance of 21.46 to confirm the risk estimate we provide.
At present, Processa Pharmaceuticals' Total Stockholder Equity is projected to increase significantly based on the last few years of reporting. The current year's Liabilities And Stockholders Equity is expected to grow to about 8.3 M, whereas Common Stock Shares Outstanding is forecasted to decline to about 1 M. . At present, Processa Pharmaceuticals' Price To Sales Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price Sales Ratio is expected to grow to 665.16, whereas Price Earnings Ratio is forecasted to decline to (0.83). Processa Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 10th of October 2017 | 200 Day MA 1.7258 | 50 Day MA 1.2051 | Beta 0.597 |
Processa |
Sharpe Ratio = -0.0429
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | PCSA |
Estimated Market Risk
| 4.72 actual daily | 42 58% of assets are more volatile |
Expected Return
| -0.2 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.04 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Processa Pharmaceuticals is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Processa Pharmaceuticals by adding Processa Pharmaceuticals to a well-diversified portfolio.
Price Book 0.8606 | Book Value 1.139 | Enterprise Value 407.3 K | Enterprise Value Ebitda (0.14) | Shares Float 2.9 M |
Related Headline
Eliem Therapeutics Headline on 5th of April 2024
ELYM Stock Earnings Eliem Therapeutics Reported Results for ... by investorplace.com
Eliem Therapeutics just reported results for the fourth quarter of 2023.
Processa Pharmaceuticals Valuation on April 5, 2024
It is possible to determine the worth of Processa Pharmaceuticals on a given historical date. On April 5, 2024 Processa was worth 2.41 at the beginning of the trading date compared to the closed value of 2.79. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Processa Pharmaceuticals stock. Still, in general, we apply an absolute valuation method to find Processa Pharmaceuticals' value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Processa Pharmaceuticals where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Processa Pharmaceuticals' related companies.
| Open | High | Low | Close | Volume | |
| 2.32 | 2.55 | 2.28 | 2.32 | 317,622 | |
04/05/2024 | 2.41 | 2.94 | 2.30 | 2.79 | 922,459 |
| 2.85 | 3.05 | 2.56 | 2.99 | 401,327 |
| Backtest Processa Pharmaceuticals | | | Processa Pharmaceuticals History | | | Processa Pharmaceuticals Valuation | Previous | Next |
Processa Pharmaceuticals Trading Date Momentum on April 5, 2024
| On April 08 2024 Processa Pharmaceuticals was traded for 2.99 at the closing time. The top price for the day was 3.05 and the lowest listed price was 2.56 . The trading volume for the day was 401.3 K. The trading history from April 8, 2024 was a factor to the next trading day price jump. The trading delta at closing time against the next closing price was 7.17% . The trading delta at closing time against the current closing price is 41.94% . |
Processa Pharmaceuticals Fundamentals Correlations and Trends
By evaluating Processa Pharmaceuticals' financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Processa Pharmaceuticals' main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Processa financial account trend analysis is a perfect complement when working with valuation or volatility modules.About Processa Pharmaceuticals Stock history
Processa Pharmaceuticals investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Processa is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Processa Pharmaceuticals will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Processa Pharmaceuticals stock prices may prove useful in developing a viable investing in Processa Pharmaceuticals
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 1.3 M | 1 M | |
| Net Loss | -10.3 M | -9.8 M |
Processa Pharmaceuticals Stock Technical Analysis
Processa Pharmaceuticals technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Price Boundaries
Processa Pharmaceuticals Period Price Range
Low | November 30, 2024
| High |
0.00 | 0.00 |
Processa Pharmaceuticals cannot be verified against its exchange. Please verify the symbol is currently traded on NASDAQ Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.
Processa Pharmaceuticals November 30, 2024 Market Strength
Market strength indicators help investors to evaluate how Processa Pharmaceuticals stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Processa Pharmaceuticals shares will generate the highest return on investment. By undertsting and applying Processa Pharmaceuticals stock market strength indicators, traders can identify Processa Pharmaceuticals entry and exit signals to maximize returns
Processa Pharmaceuticals Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Processa Pharmaceuticals' price direction in advance. Along with the technical and fundamental analysis of Processa Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Processa to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | (0.03) | |||
| Jensen Alpha | (0.40) | |||
| Total Risk Alpha | (1.00) | |||
| Treynor Ratio | (0.16) |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for Processa Stock analysis
When running Processa Pharmaceuticals' price analysis, check to measure Processa Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Processa Pharmaceuticals is operating at the current time. Most of Processa Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Processa Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Processa Pharmaceuticals' price. Additionally, you may evaluate how the addition of Processa Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Bonds Directory Find actively traded corporate debentures issued by US companies | |
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing |